CXCR4 and ovarian carcinoma: We thus concluded that the obtained CD44v6-O-MWNTS could effectively load drugs and CXCR4 siRNA, internalized by cancer cells and realized notable in vitro and in vivo inhibitory function against ovarian cancer growth.